Ovarian hyperstimulation syndrome: Difference between revisions
 
(19 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Fertility treatments causing development of multiple follicles at once
*Fertility treatments causing development of multiple follicles at once
*Fluid shifts out of vasculature
**Exaggerated ovarian response to ovulation induction (esp in IVF when HCG is used to stimulate)
*Fluid shifts out of vasculature (third spacing)
*Typically 5-10d after 1st dose
*Ranges in severity from mild to severe multiorgan dysfunction, relating in part to massive intravascular fluid shifts


==Clinical Features==
==Clinical Features==
Line 7: Line 10:
*Movement of fluid out of vasculature
*Movement of fluid out of vasculature
**[[Ascites]]
**[[Ascites]]
**Pleural effusions
**[[Pleural effusions]]
**Pericardial effusion
**[[Pericardial effusion]]
**[[Hypotension]]
**[[Hypotension]]
*[[Electrolyte Imbalances]]
*[[Electrolyte imbalances]]
*[[DIC]]
*[[DIC]]
*[[Thromboembolism]]
*[[Thromboembolism]]
Line 17: Line 20:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Ectopic Pregnancy]]
*[[Ectopic pregnancy]]
*Molar Pregnancy
*[[Molar pregnancy]]
*[[Sepsis]]
*[[Sepsis]]
*[[PE]]
*[[Pulmonary embolism in pregnancy]]


{{Pelvic pain DDX}}
{{Pelvic pain DDX}}


==Diagnosis==
==Evaluation==
[[File:Vaginal ultrasonography in mild ovarian hyperstimulation syndrome - sagittal.jpg|thumb|Pelvic ultrasound (sagittal) in woman with OHSS showing ascites and enlarged ovary (diameter = 6.5mm)]]
===Workup===
===Workup===
*Urine pregnancy
*Urine or serum pregnancy
**'''[[Beta-HCG]] may be positive if [[beta-HCG]] injection given as part of fertility treatment'''
**'''[[Beta-HCG]] may be positive if [[beta-HCG]] injection given as part of fertility treatment, consider obtaining beta quantitative instead of qualitative'''
*Pelvic ultrasound
*CBC
*CBC
*Chem 10
*Chem 10
*CXR
*PT/PTT
*PT/PTT
*[[Pelvic ultrasound]]
*Consider:
*Consider:
**Cardiac US
**[[CXR]] (rule out [[pleural effusion]])
**Cardiac [[ultrasound]] (rule out [[pericardial effusion]])
**Progesterone level
**Progesterone level
**Estradiol level
**Estradiol level
**Fibrinogen
**Fibrinogen (rule out [[DIC]])


===Evaluation<ref>Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd</ref>.===
===Evaluation<ref>Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd</ref>.===
Line 56: Line 60:
*Ultrasonographic evidence of [[ascites]]
*Ultrasonographic evidence of [[ascites]]
||
||
*Elevated Hct (>41%)  
*Elevated hematocrit (>41%)  
*Elevated WBC (>15,000/mL)  
*Elevated WBC (>15,000/mL)  
*Hypoproteinemia
*Hypoproteinemia
Line 73: Line 77:
*[[Venous thrombosis]]
*[[Venous thrombosis]]
||
||
*Hemoconcentration (Hct >55%)  
*Hemoconcentration (hematocrit >55%)  
*WBC >25,000/mL  
*WBC >25,000/mL  
*Serum creatinine >1.6 mg/dL  
*Serum creatinine >1.6mg/dL  
*Creatinine clearance <50 mL/min  
*Creatinine clearance <50 mL/min  
*[[Hyponatremia]] (Na+ <135 mEq/L)  
*[[Hyponatremia]] (Na+ <135 mEq/L)  
Line 93: Line 97:
||Worsening findings
||Worsening findings
|}
|}


==Management==
==Management==
Line 103: Line 105:
*Pain control
*Pain control
**[[Acetaminophen]], [[Norco]], or [[morphine]]
**[[Acetaminophen]], [[Norco]], or [[morphine]]
*Encourage oral fluids (1-2 liters/day)
*Ambulate, but avoid other physical activity. Avoid sexual intercourse


===Moderate===
===Moderate===
*[[IV fluids]] (e.g normal saline)
*[[IV fluids]] (e.g normal saline)
*Threaputic [[paracentesis]] if ascites  
*Therapeutic [[paracentesis]] if [[ascites]] (aspirate 0.5-4 L)
**Aspirate 0.5-4 L
*Thromboembolic prophylaxis (e.g. [[LMWH]])
*Thromboembolic prophylaxis (e.g. [[LMWH]])
**All hospitalized patients
**All hospitalized patients
Line 116: Line 119:
***Personal or family history of thrombosis
***Personal or family history of thrombosis
***Thrombophilias
***Thrombophilias
***pregnancy
***Pregnancy


===Severe===
===Severe===
Line 132: Line 135:
***Increasing abdominal girth
***Increasing abdominal girth
*Moderate: outpatient if close follow-up (discuss with GYN)
*Moderate: outpatient if close follow-up (discuss with GYN)
**Encourage oral fluids (1-2 liters/day)
**Ambulate, but avoid other physical activity. Avoid sexual intercourse
**Daily weights, abdominal circumference measurements, and urinary output recordings
*Severe: admit
*Severe: admit
*Critical: ICU
*Critical: ICU

Latest revision as of 19:06, 15 April 2020

Background

  • Fertility treatments causing development of multiple follicles at once
    • Exaggerated ovarian response to ovulation induction (esp in IVF when HCG is used to stimulate)
  • Fluid shifts out of vasculature (third spacing)
  • Typically 5-10d after 1st dose
  • Ranges in severity from mild to severe multiorgan dysfunction, relating in part to massive intravascular fluid shifts

Clinical Features

Differential Diagnosis

Acute Pelvic Pain

Differential diagnosis of acute pelvic pain

Gynecologic/Obstetric

Genitourinary

Gastrointestinal

Musculoskeletal

Vascular

Evaluation

Pelvic ultrasound (sagittal) in woman with OHSS showing ascites and enlarged ovary (diameter = 6.5mm)

Workup

Evaluation[2].

Classification Clinical features Lab findings
Mild Normal
Moderate Above plus:
  • Ultrasonographic evidence of ascites
  • Elevated hematocrit (>41%)
  • Elevated WBC (>15,000/mL)
  • Hypoproteinemia
Severe Above plus:
  • Hemoconcentration (hematocrit >55%)
  • WBC >25,000/mL
  • Serum creatinine >1.6mg/dL
  • Creatinine clearance <50 mL/min
  • Hyponatremia (Na+ <135 mEq/L)
  • Hyperkalemia (K+ >5 mEq/L)
  • Elevated liver enzymes
Critical Above plus: Worsening findings

Management

Pregnant patients must be followed very closely, as they are likely to worsen

  • Urgent GYN consultation for all

Mild

  • Pain control
  • Encourage oral fluids (1-2 liters/day)
  • Ambulate, but avoid other physical activity. Avoid sexual intercourse

Moderate

  • IV fluids (e.g normal saline)
  • Therapeutic paracentesis if ascites (aspirate 0.5-4 L)
  • Thromboembolic prophylaxis (e.g. LMWH)
    • All hospitalized patients
    • Outpatients with 2-3 risk factors:
      • Age >35 years
      • Obesity
      • Immobility
      • Personal or family history of thrombosis
      • Thrombophilias
      • Pregnancy

Severe

Critical

  • As above + resuscitative care

Disposition

  • Mild: outpatient
    • Avoid heavy physical activity
    • Return for
      • Worsening abdominal pain
      • Weight gain (>1 kg/day)
      • Increasing abdominal girth
  • Moderate: outpatient if close follow-up (discuss with GYN)
  • Severe: admit
  • Critical: ICU

Complications

See Also

References

  1. ↑ Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
  2. ↑ Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd
Retrieved from "https://www.wikem.org/w/index.php?title=Ovarian_hyperstimulation_syndrome&oldid=252364"